US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

28.30

-0.0500-0.18%

Post-market: 28.300.00000.00%16:39 EDT

Volume:3.20M

Turnover:90.81M

Market Cap:7.98B

PE:76.08

High:28.97

Open:28.72

Low:28.07

Close:28.35

52wk High:33.66

52wk Low:14.19

Shares:282.15M

Float Shares:116.00M

Volume Ratio:0.89

T/O Rate:2.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3720

EPS(LYR):-3.2200

ROE:20.13%

ROA:8.77%

PB:13.49

PE(LYR):-8.79

Loading ...

Overview Company News Filings

CAI Corp Shareholders Unanimously Back Board, Auditor and Capital Mandates at AGM

Stock Track | Caris Life Sciences Plunges 9.83% in Pre-market Despite Earnings Beat Amid Quarterly Loss and Estimate Revisions

Stock Track | Caris Life Sciences Plunges 10.28% in Extended Trading Despite Earnings Beat

Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31

Caris Life Sciences Earnings Call Signals Profitable Surge

Caris Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Caris Lifesciences Shares Slump in Extended Trade Following Results, Last Down 14.6% at $16.94

THOMSON REUTERS

Caris Life Sciences reports Q1 EPS 0c, consensus (2c)

Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B

Earnings Flash (CAI) Caris Life Sciences Posts Q1 EPS $0.0, vs. FactSet Est of -$0.02

MT Newswires Live

Caris Life Sciences Q1 revenue rises on demand for molecular profiling services

Caris Q1 net loss narrows to $0.5 million; revenue rises 79% to $216 million

Caris Life Sciences Q1 Sales $216.174M Beat $210.292M Estimate

Benzinga Earnings

Caris Life Sciences Inc - Reaffirms FY2026 Revenue Guidance of $1.0 Bln-$1.02 Bln

THOMSON REUTERS

CAI Launches Next Chapter with Investment from JLL Partners

Press Release: AudioCodes Reports First Quarter 2026 Results

BRIEF-Caris Life Sciences Receives Moldx Approval For Caris Chromoseq, Advancing Access To Comprehensive Genomic Profiling For Myeloid Malignancies

Caris wins MolDX approval for ChromoSeq myeloid malignancy genome profiling test

Earning Preview: Caris Life Sciences, Inc. revenue this quarter is expected to decrease by 28%, and institutional views are broadly bullish

Caris study validates AI signature predicting temozolomide benefit in glioblastoma patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/CAI/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":28.3,"timestamp":1790971200000,"preClose":28.35,"halted":0,"volume":3204039,"hourTrading":{"tag":"盘后","latestPrice":28.3,"preClose":28.3,"latestTime":"16:39 EDT","volume":74093,"amount":2096881.320031,"timestamp":1790973553831,"change":0,"changeRate":0,"amplitude":0.024735},"delay":0,"changeRate":-0.001763668430335122,"floatShares":115999999,"shares":282146923,"eps":0.372,"marketStatus":"Post-Mkt","change":-0.05,"latestTime":"10-02 16:42:39 EDT","open":28.72,"high":28.97,"low":28.07,"amount":90807431.52045001,"amplitude":0.031746,"askPrice":29.8,"askSize":20,"bidPrice":28.09,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.372,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":28.35,"preHourTrading":{"tag":"盘前","latestPrice":28.66,"preClose":28.35,"latestTime":"09:29 EDT","volume":1137,"amount":32401.049205,"timestamp":1790947757045,"change":0.31,"changeRate":0.010935,"amplitude":0.015873},"postHourTrading":{"tag":"盘后","latestPrice":28.3,"preClose":28.3,"latestTime":"16:39 EDT","volume":74093,"amount":2096881.320031,"timestamp":1790973553831,"change":0,"changeRate":0,"amplitude":0.024735},"volumeRatio":0.894549,"impliedVol":0.7011,"impliedVolPercentile":0.4143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","floatShares":115999999,"roa":"8.77%","roe":"20.13%","lyrEps":-3.22,"volumeRatio":0.894549,"shares":282146923,"dividePrice":0,"high":28.97,"amplitude":0.031746,"preClose":28.35,"low":28.07,"week52Low":14.19,"pbRate":"13.49","psRate":"8.07","week52High":33.655,"institutionHeld":0,"latestPrice":28.3,"committee":-0.904762,"eps":0.372,"divideRate":0,"volume":3204039,"delay":0,"ttmEps":0.372,"open":28.72,"prevYearClose":26.98,"prevWeekClose":31.98,"prevMonthClose":30.63,"prevQuarterClose":30.63,"fiveDayClose":31.98,"twentyDayClose":25.32,"sixtyDayClose":17.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"CAI","fiscalQuarterEnding":"2026/06","expectedEps":-0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2026-05-07","symbol":"CAI","fiscalQuarterEnding":"2026/03","expectedEps":-0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2026-02-26","symbol":"CAI","fiscalQuarterEnding":"2025/12","expectedEps":0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2026-01-12","symbol":"CAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CAI","date":"2026-10-01","current":76.075269,"percent":0.801153,"low":-88.150592,"twenty":-40.908527,"median":-30.48612,"eighty":81.632337,"high":165.024421,"avg":4.641026,"sd":73.828829,"marketCap":8655890547},"quantilePoints":[{"date":"2021-10-07","current":9.380344,"twenty":4.238981,"median":11.370724,"eighty":29.050072,"marketCap":969664897},{"date":"2021-10-15","current":9.378667,"twenty":4.266668,"median":11.380332,"eighty":29.050823,"marketCap":969491526},{"date":"2021-10-22","current":9.378667,"twenty":4.284214,"median":11.383933,"eighty":29.120677,"marketCap":969491526},{"date":"2021-10-29","current":9.382021,"twenty":4.305342,"median":11.383933,"eighty":29.120677,"marketCap":969838269},{"date":"2021-11-05","current":9.383698,"twenty":4.32826,"median":11.383933,"eighty":29.120677,"marketCap":970011640},{"date":"2021-11-09","current":6.915273,"twenty":4.340793,"median":11.383933,"eighty":29.120677,"marketCap":961803774},{"date":"2025-06-20","current":-27.445954,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7736739976},{"date":"2025-06-27","current":-26.374479,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7434701838},{"date":"2025-07-03","current":-26.167427,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7376335954},{"date":"2025-07-11","current":-26.246304,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7398570576},{"date":"2025-07-18","current":-30.845816,"twenty":9.382356,"median":19.818182,"eighty":28.465108,"marketCap":8695126991},{"date":"2025-07-25","current":-29.076014,"twenty":9.380344,"median":19.818182,"eighty":28.465108,"marketCap":8196237652},{"date":"2025-08-01","current":-27.685808,"twenty":9.378667,"median":19.818182,"eighty":28.465108,"marketCap":7804352434},{"date":"2025-08-08","current":-28.188649,"twenty":9.377325,"median":19.778051,"eighty":28.363181,"marketCap":7946098151},{"date":"2025-08-15","current":-37.278729,"twenty":9.37397,"median":15.016779,"eighty":28.059445,"marketCap":10402480346},{"date":"2025-08-22","current":-38.41755,"twenty":9.371958,"median":14.936518,"eighty":27.857377,"marketCap":10720263606},{"date":"2025-08-29","current":-38.528408,"twenty":9.368604,"median":14.909765,"eighty":27.685829,"marketCap":10751198260},{"date":"2025-09-05","current":-36.633734,"twenty":9.365249,"median":14.888362,"eighty":27.527351,"marketCap":10222496907},{"date":"2025-09-12","current":-34.47703,"twenty":9.360553,"median":14.824668,"eighty":27.293717,"marketCap":9620677282},{"date":"2025-09-19","current":-33.690942,"twenty":7.38442,"median":14.763781,"eighty":26.71778,"marketCap":9401322465},{"date":"2025-09-26","current":-29.962061,"twenty":-25.851919,"median":14.718778,"eighty":26.293958,"marketCap":8360793206},{"date":"2025-10-03","current":-29.941905,"twenty":-26.165455,"median":11.559155,"eighty":25.35941,"marketCap":8355168724},{"date":"2025-10-10","current":-31.504003,"twenty":-26.421805,"median":11.424439,"eighty":24.232627,"marketCap":8791066116},{"date":"2025-10-17","current":-32.199389,"twenty":-27.275648,"median":11.239535,"eighty":23.200759,"marketCap":8985110761},{"date":"2025-10-24","current":-31.907126,"twenty":-27.85145,"median":10.925198,"eighty":22.717001,"marketCap":8903555765},{"date":"2025-10-31","current":-31.413301,"twenty":-29.076014,"median":10.711237,"eighty":22.474875,"marketCap":8765755945},{"date":"2025-11-07","current":-37.133331,"twenty":-29.570316,"median":10.518408,"eighty":22.474875,"marketCap":6943635775},{"date":"2025-11-14","current":-36.66558,"twenty":-29.872671,"median":10.079921,"eighty":22.474875,"marketCap":6856170228},{"date":"2025-11-21","current":-36.258185,"twenty":-30.266418,"median":9.392084,"eighty":22.474875,"marketCap":6779990559},{"date":"2025-11-28","current":-38.521493,"twenty":-30.494182,"median":9.38873,"eighty":22.474875,"marketCap":7203210944},{"date":"2025-12-05","current":-42.731244,"twenty":-30.709853,"median":9.383698,"eighty":22.390599,"marketCap":7990400859},{"date":"2025-12-12","current":-40.045453,"twenty":-31.411285,"median":9.382021,"eighty":21.98126,"marketCap":7488179336},{"date":"2025-12-19","current":-42.037163,"twenty":-31.770064,"median":9.380344,"eighty":21.917049,"marketCap":7860613274},{"date":"2025-12-26","current":-42.610535,"twenty":-32.023314,"median":9.378667,"eighty":21.917049,"marketCap":7967829105},{"date":"2026-01-02","current":-40.709356,"twenty":-33.019743,"median":9.376989,"eighty":21.917049,"marketCap":7612323982},{"date":"2026-01-09","current":-42.625623,"twenty":-33.660707,"median":9.375312,"eighty":21.911699,"marketCap":7970650574},{"date":"2026-01-16","current":-40.920598,"twenty":-34.325859,"median":9.371958,"eighty":14.957921,"marketCap":7651824551},{"date":"2026-01-23","current":-38.55167,"twenty":-35.122025,"median":9.368604,"eighty":14.936518,"marketCap":7208853882},{"date":"2026-01-30","current":-38.023565,"twenty":-36.062032,"median":9.366927,"eighty":14.901739,"marketCap":7110102459},{"date":"2026-02-06","current":-32.063522,"twenty":-36.001677,"median":9.365249,"eighty":14.891037,"marketCap":5995622113},{"date":"2026-02-13","current":-31.158199,"twenty":-36.001677,"median":9.358541,"eighty":14.824668,"marketCap":5826333959},{"date":"2026-02-20","current":-31.459973,"twenty":-36.001677,"median":6.916509,"eighty":14.791194,"marketCap":5882763344},{"date":"2026-02-27","current":-79.83495,"twenty":-36.095748,"median":-25.920936,"eighty":14.746309,"marketCap":5435802106},{"date":"2026-03-06","current":-79.767155,"twenty":-36.689445,"median":-26.167427,"eighty":11.649494,"marketCap":5431186043},{"date":"2026-03-13","current":-73.417324,"twenty":-37.230355,"median":-26.433637,"eighty":11.50157,"marketCap":4998838767},{"date":"2026-03-20","current":-78.065566,"twenty":-37.948121,"median":-27.000565,"eighty":11.33727,"marketCap":5315328276},{"date":"2026-03-27","current":-76.073463,"twenty":-38.51833,"median":-27.544452,"eighty":11.081046,"marketCap":5179689915},{"date":"2026-04-02","current":-79.393635,"twenty":-38.55167,"median":-28.040754,"eighty":10.896141,"marketCap":5405753850},{"date":"2026-04-10","current":-79.684151,"twenty":-38.689657,"median":-29.080944,"eighty":10.700671,"marketCap":5425534444},{"date":"2026-04-17","current":-84.66441,"twenty":-39.396638,"median":-29.538348,"eighty":10.447088,"marketCap":5764630347},{"date":"2026-04-24","current":-82.156794,"twenty":-39.864388,"median":-29.869713,"eighty":9.998035,"marketCap":5593891765},{"date":"2026-05-01","current":-78.877164,"twenty":-40.407582,"median":-30.254324,"eighty":9.392084,"marketCap":5370588355},{"date":"2026-05-08","current":165.024421,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5608024892},{"date":"2026-05-15","current":126.854033,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4310880598},{"date":"2026-05-22","current":132.593658,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4505930278},{"date":"2026-05-29","current":138.666015,"twenty":-40.929651,"median":-30.496198,"eighty":9.387052,"marketCap":4712287185},{"date":"2026-06-05","current":143.740176,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4884722409},{"date":"2026-06-12","current":149.72935,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5088252510},{"date":"2026-06-18","current":148.564789,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5048677212},{"date":"2026-06-26","current":155.552158,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5286128996},{"date":"2026-07-02","current":155.968073,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5300263031},{"date":"2026-07-10","current":148.647972,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5051504019},{"date":"2026-07-17","current":137.085538,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4658577853},{"date":"2026-07-24","current":130.181352,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4423952876},{"date":"2026-07-31","current":133.841403,"twenty":-40.929651,"median":-30.496198,"eighty":9.387052,"marketCap":4548332382},{"date":"2026-08-07","current":53.756202,"twenty":-40.929651,"median":-30.496198,"eighty":9.389065,"marketCap":5651658300},{"date":"2026-08-14","current":59.618217,"twenty":-40.929651,"median":-30.496198,"eighty":9.397451,"marketCap":6267961225},{"date":"2026-08-21","current":66.069241,"twenty":-40.929651,"median":-30.496198,"eighty":58.231247,"marketCap":6946189671},{"date":"2026-08-28","current":70.907509,"twenty":-40.914563,"median":-30.48612,"eighty":61.166462,"marketCap":7454861006},{"date":"2026-09-04","current":68.058307,"twenty":-40.914563,"median":-30.48612,"eighty":66.649833,"marketCap":7155310109},{"date":"2026-09-11","current":64.617761,"twenty":-40.914563,"median":-30.48612,"eighty":67.251929,"marketCap":6793588271},{"date":"2026-09-18","current":83.110697,"twenty":-40.914563,"median":-30.48612,"eighty":69.794708,"marketCap":8737843151},{"date":"2026-09-25","current":86.739398,"twenty":-40.914563,"median":-30.48612,"eighty":74.649103,"marketCap":9119346652},{"date":"2026-10-01","current":82.331198,"twenty":-40.908527,"median":-30.48612,"eighty":81.632337,"marketCap":8655890547}],"updateTime":1790973759594},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CAI\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633435250","title":"CAI Corp Shareholders Unanimously Back Board, Auditor and Capital Mandates at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435250","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633435250?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:41","pubTimestamp":1778229695,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has issued an announcement. CAI Corp reported that all resolutions at its 8 May 2026 annual general meet...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-shareholders-unanimously-back-board-auditor-and-capital-mandates-at-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-shareholders-unanimously-back-board-auditor-and-capital-mandates-at-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4229","BK4195","BK4139","BK4104","CAI","AGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186287248","title":"Stock Track | Caris Life Sciences Plunges 9.83% in Pre-market Despite Earnings Beat Amid Quarterly Loss and Estimate Revisions","url":"https://stock-news.laohu8.com/highlight/detail?id=1186287248","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186287248?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:16","pubTimestamp":1778228176,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc. (CAI) experienced a pre-market plunge of 9.83% on Friday, following the release of its quarterly earnings results.Despite reporting breakeven earnings per share for the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179254258","title":"Stock Track | Caris Life Sciences Plunges 10.28% in Extended Trading Despite Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1179254258","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179254258?lang=en_us&edition=fundamental","pubTime":"2026-05-08 15:41","pubTimestamp":1778226077,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. (CAI) experienced a significant 24-hour plunge of 10.28%, with the sharp decline occurring primarily in extended trading sessions following the release of its quarterly...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633482338","title":"Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2633482338","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633482338?lang=en_us&edition=fundamental","pubTime":"2026-05-08 14:35","pubTimestamp":1778222133,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc., the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Daniel Brennan from TD Cowen mainta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-as-strong-revenue-improving-profitability-offset-near-term-risks-price-target-trimmed-to-31-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-as-strong-revenue-improving-profitability-offset-near-term-risks-price-target-trimmed-to-31-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","BK4581","LABU","BK4139","CAI","BK4585","XBI","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633243100","title":"Caris Life Sciences Earnings Call Signals Profitable Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2633243100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633243100?lang=en_us&edition=fundamental","pubTime":"2026-05-08 10:50","pubTimestamp":1778208653,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc. (($CAI)) has held its Q1 earnings call. Read on for the main highlights of the call. Caris Life Sciences’ latest earnings...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/caris-life-sciences-earnings-call-signals-profitable-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/caris-life-sciences-earnings-call-signals-profitable-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633060801","title":"Caris Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633060801","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633060801?lang=en_us&edition=fundamental","pubTime":"2026-05-08 08:03","pubTimestamp":1778198601,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc reports results for the quarter ended March 31 - Earnings SummaryCaris Life Sciences Inc CAI.OQ reported quarterly breakeven results per share for the quarter ended March 31.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L00K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633108593","title":"Caris Lifesciences Shares Slump in Extended Trade Following Results, Last Down 14.6% at $16.94","url":"https://stock-news.laohu8.com/highlight/detail?id=2633108593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633108593?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:40","pubTimestamp":1778190033,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL6N41K1E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633157170","title":"Caris Life Sciences reports Q1 EPS 0c, consensus (2c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633157170","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633157170?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:18","pubTimestamp":1778188699,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $216.2M, consensus $209.67M. “We delivered another strong quarter with record performance for February and March following our J...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-reports-q1-eps-0c-consensus-2c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-reports-q1-eps-0c-consensus-2c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170128","title":"Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170128?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:17","pubTimestamp":1778188638,"startTime":"0","endTime":"0","summary":"16:24 EDT Caris Life Sciences (CAI) still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B Published first on TheFly – the ultimate source for real...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-still-sees-2026-revenue-1-0b-1-02b-consensus-1-01b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-still-sees-2026-revenue-1-0b-1-02b-consensus-1-01b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633704091","title":"Earnings Flash (CAI) Caris Life Sciences Posts Q1 EPS $0.0, vs. FactSet Est of -$0.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2633704091","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633704091?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:17","pubTimestamp":1778188622,"startTime":"0","endTime":"0","summary":"Earnings Flash (CAI) Caris Life Sciences Posts Q1 EPS $0.0, vs. FactSet Est of -$0.02","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAI.AU","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633172034","title":"Caris Life Sciences Q1 revenue rises on demand for molecular profiling services","url":"https://stock-news.laohu8.com/highlight/detail?id=2633172034","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633172034?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:52","pubTimestamp":1778187167,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Q1 revenue rises on demand for molecular profiling servicesOverviewPrecision medicine firm's Q1 revenue rose 79% yr/yr, driven by molecular profiling servicesGross margin improved ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K1K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633550171","title":"Caris Q1 net loss narrows to $0.5 million; revenue rises 79% to $216 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633550171","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633550171?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:18","pubTimestamp":1778185134,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Q1 2026 revenue rose 79% to $216 million.Net loss narrowed to $0.5 million, while gross margin expanded 18 percentage points to 65%.Molecular profiling revenue climbed 85% to $210.8 million on 15% higher volume of 52,800 completed clinical cases.Adjusted EBITDA swung to a gain of $26.2 million, free cash flow turned positive at $22.5 million, cash and marketable securities totaled $825.7 million.Caris reaffirmed 2026 revenue guidance of $1 billion to $1.02 billion, expecting molecular profiling revenue of $925 million to $935 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLb6pPTs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633296179","title":"Caris Life Sciences Q1 Sales $216.174M Beat $210.292M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633296179","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633296179?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:15","pubTimestamp":1778184956,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (NASDAQ:CAI) reported quarterly sales of $216.174 million which beat the analyst consensus estimate of $210.292 million by 2.80 percent.  This is a 78.78 percent increase over sales of $120.915","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52389460/caris-life-sciences-q1-sales-216-174m-beat-210-292m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Caris Life Sciences Q1 Sales $216.174M Beat $210.292M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633317945","title":"Caris Life Sciences Inc - Reaffirms FY2026 Revenue Guidance of $1.0 Bln-$1.02 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633317945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633317945?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXC56491:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633994239","title":"CAI Launches Next Chapter with Investment from JLL Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2633994239","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633994239?lang=en_us&edition=fundamental","pubTime":"2026-05-06 00:00","pubTimestamp":1777996800,"startTime":"0","endTime":"0","summary":"INDIANAPOLIS, May 5, 2026 /PRNewswire/ -- CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments, today announced thatit has entered into an agreement withJLLPartners, a New York-based middle-market private equity firm focused on investing in the healthcare, industrials, and business services sectors, to support the next phase of growth for CAI.This partnership positions CAI to expand its global footprint, invest in next-generation technologies, and enhance its service offerings to better support customers operating in complex, technically demanding, and highly regulated environments.About CAICAI is a professional services firm composed of engineering, quality, and operations experts dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments. With deep roots in CQV , CAI has evolved over the past 30 years alongside the industries it serves,","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2972509/CAI_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2972509/CAI_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/cai-launches-next-chapter-with-investment-from-jll-partners-302762786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4079","BK4104","BK4139","LU0029874061.USD","CAI","JLL","LU0054578231.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633991014","title":"Press Release: AudioCodes Reports First Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633991014","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633991014?lang=en_us&edition=fundamental","pubTime":"2026-05-05 14:00","pubTimestamp":1777960800,"startTime":"0","endTime":"0","summary":"-- Quarterly revenues increased by 2.9% year-over-year to $62.1 million;-- Quarterly services revenues increased by 4.3% year-over-year to $34.0. Revenues for the first quarter of 2026 were $62.1 million compared to $60.4 million for the first quarter of 2025.Net income was $2.0 million, or $0.07 per diluted share, for the first quarter of 2026 compared to net income of $4.0 million, or $0.13 per diluted share, for the first quarter of 2025.On a Non-GAAP basis, net income was $3.8 million, or $0.14 per diluted share, for the first quarter of 2026 compared to $4.7 million, or $0.15 per diluted share, for the first quarter of 2025.Net cash provided by operating activities was $12.8 million for the first quarter of 2026. Cash and cash equivalents, short-term bank deposits, short-term marketable securities, and long-term financial investments were $68.1 million as of March 31, 2026 compared to $75.7 million as of December 31, 2025. The decrease in cash and cash equivalents, short-term bank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","AI","BK4528","BK4585","BK4139","ARTY","BK4023","ARR","AGIX","AIPO","BK4543","AIYY","BK4551","AUDC","BK4588","CHAT","BK4587","BK4104","BK4110","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632595318","title":"BRIEF-Caris Life Sciences Receives Moldx Approval For Caris Chromoseq, Advancing Access To Comprehensive Genomic Profiling For Myeloid Malignancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2632595318","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632595318?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:33","pubTimestamp":1777897996,"startTime":"0","endTime":"0","summary":"BRIEF-Caris Life Sciences Receives Moldx Approval For Caris Chromoseq, Advancing Access To Comprehensive Genomic Profiling For Myeloid MalignanciesMay 4 (Reuters) - Caris Life Sciences Inc CAI.O:CARIS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H0CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632539489","title":"Caris wins MolDX approval for ChromoSeq myeloid malignancy genome profiling test","url":"https://stock-news.laohu8.com/highlight/detail?id=2632539489","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632539489?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:31","pubTimestamp":1777897899,"startTime":"0","endTime":"0","summary":"Caris Life Sciences received MolDX approval on May 4, 2026 for Caris ChromoSeq, supporting broader Medicare coverage pathway for its whole-genome tumor profiling test in myeloid malignancies.MolDX, administered by Palmetto GBA for CMS, cleared the assay based on clinical validity and utility review.ChromoSeq is positioned as ultra-deep whole-genome sequencing to consolidate multiple diagnostic tests into one report for diseases such as AML, MDS, MPN.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL5HpPYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121367051","title":"Earning Preview: Caris Life Sciences, Inc. revenue this quarter is expected to decrease by 28%, and institutional views are broadly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1121367051","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121367051?lang=en_us&edition=fundamental","pubTime":"2026-05-01 02:39","pubTimestamp":1777574345,"startTime":"0","endTime":"0","summary":"Abstract Caris Life Sciences, Inc. is scheduled to announce quarterly results on May 7, 2026 Post Market, with current estimates pointing to revenue of about 210.29 million US dollars and adjusted...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Caris Life Sciences, Inc. revenue this quarter is expected to decrease by 28%, and institutional views are broadly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631151191","title":"Caris study validates AI signature predicting temozolomide benefit in glioblastoma patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2631151191","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631151191?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:34","pubTimestamp":1777466041,"startTime":"0","endTime":"0","summary":"Caris Life Sciences published a peer-reviewed validation study on April 29, 2026 in Neuro-Oncology Advances for an AI-derived signature aimed at guiding temozolomide use in glioblastoma.Results were presented as published findings, with no future presentation disclosed.Study validated model’s ability to infer MGMT promoter methylation status from Caris NGS data, supporting treatment selection for IDH-wild type glioblastoma patients receiving temozolomide.Caris reported signature improved separation of survival outcomes across patient subgroups versus traditional MGMT testing variability, positioning tool as a complement to existing assays.Work drew on a 5,841-patient development dataset, with additional evaluation in a prospective cohort of more than 3,400 cases, supporting potential commercial pull-through for MI Cancer Seek and Caris Molecular Tumor Board Report.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strive","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL4581wB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":114,"code":"91000000","status":"200"}]}}